bluebird bio
BLUE
#9803
Rank
$48.66 M
Marketcap
$4.97
Share price
0.00%
Change (1 day)
-75.64%
Change (1 year)

Earnings for bluebird bio (BLUE)

Earnings in 2025 (TTM): -$0.2 Billion USD

According to bluebird bio 's latest financial reports the company's current earnings are $0.10 Billion USD. In 2024 the company made an earning of -$0.25 Billion USD a decrease over its 2023 earnings that were of -$0.22 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for bluebird bio from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.2 Billion-16.97%
2024 -$0.25 Billion9.52%
2023 -$0.22 Billion-17.54%
2022 -$0.27 Billion-18.85%
2021 -$0.33 Billion-46.87%
2020 -$0.62 Billion-21.79%
2019 -$0.8 Billion42.26%
2018 -$0.56 Billion65.59%
2017 -$0.34 Billion27%
2016 -$0.27 Billion58.42%
2015 -$0.17 Billion175.54%
2014 -$60.51 Million138.96%
2013 -$25.33 Million6.98%
2012 -$23.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
$0.67 B-439.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-$0.26 Billion 27.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B-4,654.41%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-$0.11 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-11,655.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-$29.49 Million-85.24%๐Ÿ‡บ๐Ÿ‡ธ USA